Charles Kovalchick
Family Medicine · Lake Ariel, PANPI 1144215682
Payments from drug & device makers
Across 242 payments — averaging $16.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$665
- Novo Nordisk$632
- AbbVie$467
- Pfizer$393
- GSK$224
- Lilly USA, LLC$186
- plus $1K from 23 others
What the payments were for
- Food & beverage$3,956100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen | 29 | $665 |
| Novo Nordisk | 56 | $632 |
| AbbVie(2 entities) | 23 | $467 |
| Pfizer | 30 | $393 |
| GSK | 11 | $224 |
| Lilly USA, LLC | 16 | $186 |
| Boehringer Ingelheim | 9 | $165 |
| Otsuka America Pharmaceutical, Inc. | 8 | $155 |
| AstraZeneca | 10 | $146 |
| Actelion Pharmaceuticals US, Inc. | 1 | $125 |
| Verona Pharma, Inc. | 5 | $94 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 7 | $93 |
| Exact Sciences | 5 | $79 |
| Shield Therapeutics Inc | 4 | $74 |
| Xeris Pharmaceuticals, Inc. | 3 | $69 |
| Bayer | 3 | $59 |
| Johnson & Johnson | 4 | $54 |
| Abbott | 3 | $53 |
| Sumitomo Pharma America, Inc. | 2 | $36 |
| Strongbridge US Inc. | 2 | $30 |
| Medtronic | 2 | $23 |
| Dexcom, Inc. | 1 | $23 |
| Merck | 2 | $22 |
| Daiichi Sankyo Inc. | 1 | $19 |
| Lundbeck LLC | 1 | $18 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $15 |
| Aimmune Therapeutics, Inc. | 1 | $15 |
| E.r. Squibb & Sons, L.L.C. | 1 | $11 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,956 in reported general payments places this provider in the 85th percentile of 4,967 family medicine providers in Pennsylvania.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 96 | $103,335 |
| JardianceEmpagliflozin | 88 | $94,494 |
| EliquisApixaban | 113 | $92,273 |
| RybelsusSemaglutide | 42 | $56,885 |
| XareltoRivaroxaban | 42 | $54,763 |
| FarxigaDapagliflozin Propanediol | 40 | $42,539 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 55 | $40,482 |
| MounjaroTirzepatide | 23 | $37,981 |
| JanuviaSitagliptin Phosphate | 26 | $18,674 |
| EntrestoSacubitril/Valsartan | 17 | $17,381 |
| Breo ElliptaFluticasone/Vilanterol | 29 | $14,289 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 17 | $11,472 |
| Tresiba Flextouch U-200Insulin Degludec | 11 | $9,789 |
| BrilintaTicagrelor | 18 | $8,528 |
| MyrbetriqMirabegron | 13 | $7,513 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic, Rybelsus, Novolog | $632 | $163,643153 claims |
| Boehringer IngelheimJardiance, Combivent Respimat | $165 | $100,250100 claims |
| PfizerEliquis | $393 | $92,273113 claims |
| GSKTrelegy Ellipta, Breo Ellipta, Anoro Ellipta, Incruse Ellipta | $224 | $71,819113 claims |
| Johnson & JohnsonXarelto | $54 | $54,76342 claims |
| AstraZenecaFarxiga, Brilinta | $146 | $51,06758 claims |
| Lilly USA, LLCMounjaro | $186 | $37,98123 claims |
| MerckJanuvia | $22 | $18,67426 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 4,967 family medicine providers in Pennsylvania.
Other family medicine in Lake Ariel
- Kem YenalPhila$12.6M
- Marcy FleckerSmithfield$6.9M
- Tiffany PlutoScottdale$4.8M
- Bryce PalchickPittsburgh$4.7M
- Harris CohenHorsham$3.7M
- Shari RozenPittsburgh$2.9M
- Richard CookUniontown$2.1M
- Bruce GebhardtErie$2.1M
- Peter CognettiScranton$1.9M
- Bradley FoxErie$1.7M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.